• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌激素刺激人乳腺癌MCF-7细胞系中的腺苷受体表达亚型。

Estrogen stimulates adenosine receptor expression subtypes in human breast cancer MCF-7 cell line.

作者信息

Mohamadi Azam, Aghaei Mahmoud, Panjehpour Mojtaba

机构信息

Department of Biochemistry and Bioinformatics Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, I.R. Iran.

出版信息

Res Pharm Sci. 2018 Feb;13(1):57-64. doi: 10.4103/1735-5362.220968.

DOI:10.4103/1735-5362.220968
PMID:29387112
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5772082/
Abstract

Estrogen is a steroid hormone that plays a key role in the development and regulation of reproductive system. It has been shown that estrogen is related to breast cancer development through binding to its receptors. In order to uncover the estrogen effects on adenosine receptor expression, estrogen-positive MCF-7 cells were used to treat with agonist and antagonist of estrogen and then the mRNA expression of adenosine receptor subtypes were evaluated. Estrogen-positive MCF-7 cells were treated with various concentrations of 17β estradiol (E2) as an estrogen agonist, and ICI 182,780 as an estrogen antagonist. The gene expression of adenosine receptor subtypes were detected by real time RT-PCR. The results of MTT assay showed that E2 increased cell viability in a dose dependent manner. The expression pattern of all adenosine receptor subtypes are as follow; A2b > A1 > A2a > A3 in untreated MCF-7 cells. Obtained results showed that E2 incubation at 0.001-0.01 μM led to up-regulation of A1ARs, A2aARs and A3ARs dose dependently. E2 at 0.001 μM also had no significant effect on A2bARs expression but, at higher doses induced a considerable decrease in mRNA A2bARs expression. Treatment with antagonist confirmed that up-regulation of these receptors is mediated by estrogen receptor. Taken together, our results indicate that treatment of MCF-7 cells with E2 led to up-regulation of adenosine receptors. However, these effects were partially restored by treatment with antagonist suggesting that such effects are mediated by estrogen receptors.

摘要

雌激素是一种类固醇激素,在生殖系统的发育和调节中起关键作用。研究表明,雌激素通过与受体结合与乳腺癌的发生发展相关。为了揭示雌激素对腺苷受体表达的影响,使用雌激素阳性的MCF-7细胞用雌激素激动剂和拮抗剂进行处理,然后评估腺苷受体亚型的mRNA表达。用不同浓度的17β雌二醇(E2)作为雌激素激动剂,以及ICI 182,780作为雌激素拮抗剂处理雌激素阳性的MCF-7细胞。通过实时RT-PCR检测腺苷受体亚型的基因表达。MTT分析结果表明,E2以剂量依赖性方式增加细胞活力。在未处理的MCF-7细胞中,所有腺苷受体亚型的表达模式如下:A2b > A1 > A2a > A3。获得的结果表明,在0.001-0.01μM浓度下孵育E2导致A1AR、A2aAR和A3AR剂量依赖性上调。0.001μM的E2对A2bAR的表达也没有显著影响,但在较高剂量下会导致mRNA A2bAR表达显著下降。用拮抗剂处理证实这些受体的上调是由雌激素受体介导的。综上所述,我们的结果表明,用E2处理MCF-7细胞会导致腺苷受体上调。然而,用拮抗剂处理可部分恢复这些作用,表明这种作用是由雌激素受体介导的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab6b/5772082/667f0ca8ccb9/RPS-13-57-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab6b/5772082/7f011050faf4/RPS-13-57-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab6b/5772082/463c8b89abb1/RPS-13-57-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab6b/5772082/357542fd26d6/RPS-13-57-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab6b/5772082/71ac19c6e867/RPS-13-57-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab6b/5772082/b8791e0ecc4f/RPS-13-57-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab6b/5772082/667f0ca8ccb9/RPS-13-57-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab6b/5772082/7f011050faf4/RPS-13-57-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab6b/5772082/463c8b89abb1/RPS-13-57-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab6b/5772082/357542fd26d6/RPS-13-57-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab6b/5772082/71ac19c6e867/RPS-13-57-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab6b/5772082/b8791e0ecc4f/RPS-13-57-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab6b/5772082/667f0ca8ccb9/RPS-13-57-g007.jpg

相似文献

1
Estrogen stimulates adenosine receptor expression subtypes in human breast cancer MCF-7 cell line.雌激素刺激人乳腺癌MCF-7细胞系中的腺苷受体表达亚型。
Res Pharm Sci. 2018 Feb;13(1):57-64. doi: 10.4103/1735-5362.220968.
2
P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells.P2Y2 受体介导的雌激素诱导的乳腺癌细胞增殖的调节作用。
Mol Cell Endocrinol. 2011 May 16;338(1-2):28-37. doi: 10.1016/j.mce.2011.02.014. Epub 2011 Feb 26.
3
17β-estradiol induces stearoyl-CoA desaturase-1 expression in estrogen receptor-positive breast cancer cells.17β-雌二醇诱导雌激素受体阳性乳腺癌细胞中硬脂酰辅酶A去饱和酶-1的表达。
BMC Cancer. 2015 May 29;15:440. doi: 10.1186/s12885-015-1452-1.
4
Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.17β-雌二醇通过激活雌激素受体α而非雌激素受体β上调PI3K/Akt信号传导,并刺激乳腺癌细胞的生长。
Biochem Biophys Res Commun. 2005 Nov 4;336(4):1221-6. doi: 10.1016/j.bbrc.2005.08.256.
5
1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.1α,25-二羟基维生素D3下调雌激素受体丰度并抑制MCF-7人乳腺癌细胞中的雌激素作用。
Clin Cancer Res. 2000 Aug;6(8):3371-9.
6
Activation of ClC-3 chloride channel by 17β-estradiol relies on the estrogen receptor α expression in breast cancer.17β-雌二醇对ClC-3氯通道的激活依赖于乳腺癌中雌激素受体α的表达。
J Cell Physiol. 2018 Feb;233(2):1071-1081. doi: 10.1002/jcp.25963. Epub 2017 Jun 9.
7
Effect of dioxin and 17β-estradiol on the expression of cytochrome P450 1A1 gene via an estrogen receptor dependent pathway in cellular and xenografted models.二噁英和17β-雌二醇通过雌激素受体依赖性途径对细胞和异种移植模型中细胞色素P450 1A1基因表达的影响。
Environ Toxicol. 2017 Oct;32(10):2225-2233. doi: 10.1002/tox.22438. Epub 2017 Jun 15.
8
Adenosine A1 receptor, a target and regulator of estrogen receptoralpha action, mediates the proliferative effects of estradiol in breast cancer.腺苷 A1 受体是雌激素受体 alpha 作用的靶点和调节剂,介导了雌二醇在乳腺癌中的增殖作用。
Oncogene. 2010 Feb 25;29(8):1114-22. doi: 10.1038/onc.2009.409. Epub 2009 Nov 23.
9
Interplay of nuclear receptors (ER, PR, and GR) and their steroid hormones in MCF-7 cells.核受体(雌激素受体、孕激素受体和糖皮质激素受体)及其甾体激素在MCF-7细胞中的相互作用。
Mol Cell Biochem. 2016 Nov;422(1-2):109-120. doi: 10.1007/s11010-016-2810-2. Epub 2016 Sep 8.
10
Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway.雌二醇诱导的乳腺肿瘤细胞中血管内皮生长因子 -A 的表达呈双相性,并受雌激素受体 -α 依赖性途径调控。
Int J Oncol. 2003 Mar;22(3):609-14.

引用本文的文献

1
Chronic Caffeine Consumption, Alone or Combined with Agomelatine or Quetiapine, Reduces the Maximum EEG Peak, As Linked to Cortical Neurodegeneration, Ovarian Estrogen Receptor Alpha, and Melatonin Receptor 2.慢性咖啡因摄入,单独或与阿戈美拉汀或喹硫平联合使用,可降低最大 EEG 峰值,与皮质神经退行性变、卵巢雌激素受体α和褪黑素受体 2 有关。
Psychopharmacology (Berl). 2024 Oct;241(10):2073-2101. doi: 10.1007/s00213-024-06619-4. Epub 2024 Jun 6.
2
Identification of Gene Expression in Different Stages of Breast Cancer with Machine Learning.利用机器学习识别乳腺癌不同阶段的基因表达
Cancers (Basel). 2024 May 14;16(10):1864. doi: 10.3390/cancers16101864.
3

本文引用的文献

1
Adenosine A2B Receptor: From Cell Biology to Human Diseases.腺苷 A2B 受体:从细胞生物学到人类疾病。
Front Chem. 2016 Aug 24;4:37. doi: 10.3389/fchem.2016.00037. eCollection 2016.
2
Cancer statistics, 2016.癌症统计数据,2016 年。
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30. doi: 10.3322/caac.21332. Epub 2016 Jan 7.
3
Activation of A2b adenosine receptor regulates ovarian cancer cell growth: involvement of Bax/Bcl-2 and caspase-3.A2b 腺苷受体的激活调节卵巢癌细胞生长:Bax/Bcl-2 和半胱天冬酶-3 的参与
Adenosine receptors in breast cancer.
乳腺癌中的腺苷受体。
Mol Biol Rep. 2024 Mar 29;51(1):464. doi: 10.1007/s11033-024-09382-z.
4
Molecular docking analysis of triterpenoids from with breast cancer targets.来自[具体来源未给出]的三萜类化合物与乳腺癌靶点的分子对接分析。
Bioinformation. 2023 Nov 30;19(11):1067-1074. doi: 10.6026/973206300191067. eCollection 2023.
5
Regulation of Hypoxic-Adenosinergic Signaling by Estrogen: Implications for Microvascular Injury.雌激素对缺氧-腺苷能信号传导的调节:对微血管损伤的影响
Pharmaceuticals (Basel). 2023 Mar 10;16(3):422. doi: 10.3390/ph16030422.
6
Expression analysis elucidates the roles of Nicastrin, Notch4, and Hes1 in prognosis and endocrine-therapy resistance in ER-positive breast cancer patients.表达分析阐明了尼卡斯特林、Notch4和Hes1在雌激素受体阳性乳腺癌患者预后及内分泌治疗耐药中的作用。
Res Pharm Sci. 2022 Dec 24;18(1):78-88. doi: 10.4103/1735-5362.363598. eCollection 2023 Feb.
7
Nucleoside transporters and immunosuppressive adenosine signaling in the tumor microenvironment: Potential therapeutic opportunities.核苷转运体与肿瘤微环境中的免疫抑制性腺苷信号:潜在的治疗机会。
Pharmacol Ther. 2022 Dec;240:108300. doi: 10.1016/j.pharmthera.2022.108300. Epub 2022 Oct 22.
8
The Looming Effects of Estrogen in Covid-19: A Rocky Rollout.雌激素在新冠病毒肺炎中的潜在影响:艰难的推广
Front Nutr. 2021 Mar 18;8:649128. doi: 10.3389/fnut.2021.649128. eCollection 2021.
9
Targeting the purinergic pathway in breast cancer and its therapeutic applications.靶向乳腺癌中的嘌呤能途径及其治疗应用。
Purinergic Signal. 2021 Jun;17(2):179-200. doi: 10.1007/s11302-020-09760-9. Epub 2021 Feb 12.
10
Advantages in Wound Healing Process in Female Mice Require Upregulation A-Mediated Angiogenesis under the Stimulation of 17β-Estradiol.在 17β-雌二醇刺激下,A 调节的血管生成要求上调,这有利于雌性小鼠的伤口愈合过程。
Int J Mol Sci. 2020 Sep 28;21(19):7145. doi: 10.3390/ijms21197145.
Biochem Cell Biol. 2015 Aug;93(4):321-9. doi: 10.1139/bcb-2014-0117. Epub 2015 Mar 16.
4
The A3 adenosine receptor: history and perspectives.A3 腺苷受体:历史与展望。
Pharmacol Rev. 2015;67(1):74-102. doi: 10.1124/pr.113.008540.
5
Adenosine and its receptors as therapeutic targets: An overview.腺嘌呤核苷及其受体作为治疗靶点:概述。
Saudi Pharm J. 2013 Jul;21(3):245-53. doi: 10.1016/j.jsps.2012.05.011. Epub 2012 Jun 23.
6
Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study.雌激素加孕激素与妇女健康倡议观察研究中的乳腺癌发病率和死亡率。
J Natl Cancer Inst. 2013 Apr 17;105(8):526-35. doi: 10.1093/jnci/djt043. Epub 2013 Mar 29.
7
Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go?腺苷作为癌症发病机制中的内源性免疫调节剂:路在何方?
Purinergic Signal. 2013 Jun;9(2):145-65. doi: 10.1007/s11302-012-9349-9. Epub 2012 Dec 28.
8
Estrogen carcinogenesis in breast cancer.雌激素在乳腺癌中的致癌作用。
Endocrinol Metab Clin North Am. 2011 Sep;40(3):473-84, vii. doi: 10.1016/j.ecl.2011.05.009. Epub 2011 Jun 29.
9
Long-term (trophic) purinergic signalling: purinoceptors control cell proliferation, differentiation and death.长期(营养)嘌呤能信号转导:嘌呤能受体控制细胞增殖、分化和死亡。
Cell Death Dis. 2010;1(1):e9. doi: 10.1038/cddis.2009.11.
10
Adenosine receptors and cancer.腺苷受体与癌症。
Biochim Biophys Acta. 2011 May;1808(5):1400-12. doi: 10.1016/j.bbamem.2010.09.020. Epub 2010 Oct 1.